Ensuring quality control in a clinical trial during the COVID-19 pandemic: The experience of the Inserm C20-15 DisCoVeRy study in France - Archive ouverte HAL
Article Dans Une Revue Fundamental & Clinical Pharmacology Année : 2022

Ensuring quality control in a clinical trial during the COVID-19 pandemic: The experience of the Inserm C20-15 DisCoVeRy study in France

Résumé

Meeting Abstract PM2-027

Domaines

Sciences du Vivant [q-bio]

Laurent Jonchère  : Connectez-vous pour contacter le contributeur

https://hal.science/hal-03714451

Soumis le : mardi 5 juillet 2022-15:24:17

Dernière modification le : mardi 16 juillet 2024-15:14:04

Fichier non déposé

Dates et versions

hal-03714451 , version 1 (05-07-2022)

Identifiants

  • HAL Id : hal-03714451 , version 1

Citer

C. Fougerou-Leurent, C. Delmas, J. Saillard, M. Dumousseaux, A. Ferrane, et al.. Ensuring quality control in a clinical trial during the COVID-19 pandemic: The experience of the Inserm C20-15 DisCoVeRy study in France. Fundamental & Clinical Pharmacology, 2022, 36, pp.85-85. ⟨hal-03714451⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-RENNES1 CIC CIC203 UR1-UFR-SVE UNIV-RENNES UR1-BIO-SA
13 Consultations
0 Téléchargements

Partager

More